Performance History
| Key Stats | |
|---|---|
| Open | $22.13 |
| Prev. Close | $22.36 |
| EPS | -3.5 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | 69153328.00 |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 22.13 | 22.37 |
| 52 Week Range | 0.27 | 22.84 |
| Ratios | |
|---|---|
| P/B Ratio | 2.11 |
| Revenue | - |
| Operating M. % | 0.00% |
| Earnings | $0.00 |
| Earnings Growth % | 44.15% |
| EBITDA Margin % | - |
| ROE % | -61.86% |
| EPS | -3.5 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Landos Biopharma (LABP)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Gregory Oakes
- Headquarters
- Blacksburg
- Employees
- 22
- Exchange
- NASDAQ
Keep an eye on Landos Biopharma
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is Landos Biopharma's (LABP) price per share?
The current price per share for Landos Biopharma (LABP) is $22.33. The stock has seen a price change of -$0.03 recently, indicating a -0.13% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for Landos Biopharma (LABP)?
For Landos Biopharma (LABP), the 52-week high is $22.84, which is 2.28% from the current price. The 52-week low is $0.27, the current price is 8.17K% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is Landos Biopharma (LABP) a growth stock?
Landos Biopharma (LABP) has shown an average price growth of 0.41% over the past three years. It has received a score of 100 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Landos Biopharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is Landos Biopharma (LABP) stock price performance year to date (YTD)?
As of the latest data, Landos Biopharma (LABP) has a year-to-date price change of 416.9%. Over the past month, the stock has experienced a price change of 3.68%. Over the last three months, the change has been 313.52%. Over the past six months, the figure is 489.18%.
Is Landos Biopharma (LABP) a profitable company?
Landos Biopharma (LABP) has a net income of -$21.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$22.73M. Furthermore, the EBITDA is -$22.15M.
What is the market capitalization of Landos Biopharma (LABP)?
Landos Biopharma (LABP) has a market capitalization of $69.15M. The average daily trading volume is 6.08K, indicating the stock's liquidity and investor engagement.
News
Microsoft Leads in Carbon Dioxide Removal (CDR) Credit Purchases, Acquiring 6.6M Tonnes, Surpassing All Other Buyers Combined
SoftBank’s Profitability Surges Amid AI Investment Boom
Revolut Hit 26 Million Downloads in 2023, 65% more than a Year Before
US Smartphone Sales to Grow by Only 3% by 2028, 7x Less than in the Chinese Market
Xiaomi and Samsung Smartphones Identified Among Top Radiation Emitters in 2024
Traders Pile Up Short Positions as Grayscale Abandons Ethereum Futures ETF Plan
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.